mspcl - DHI

MENJONG SORIG

PHARMACEUTICALS

Menjong Sorig Pharmaceuticals was then functioning as Pharmacy unit as a cottage manufacturing facility after the establishment of Hospital in Kawangjangsa, Thimphu in 1978. The Pharmacy unit for Traditional Medicines was established in 1982 through World Health Organization funding in procuring basic manufacturing equipments such as first grinding machine, rotary tablet press, coating pan mixer and sieving machines, oven. During those days, the manufacturing of traditional medicines was run by Menpa until the recruitment of first batch of four Pharmacy Technicians.

Achievements

» Supplied a total of 9.08 metric tons (MT) of Traditional Medicines to the Ministry of Health.

 

» Sold Nu. 13.34 million of health supplements, which fell short of the target of Nu. 25 million set for 2022.

 

» Recorded net sales revenue of Nu. 75.67 million for the year, of which Nu. 62.33 million was from traditional medicines and Nu. 13.34 million from health supplements.

 

» Contributed Nu 2.80 million to the National Resilience Fund to help the government to combat COVID-19 as a part of CSR

 

» Made a positive Profit after Tax (PAT) of Nu. 8.46 million after adjustment of Nu. 4.31 million for prior year loss.


Company

Particulars

2022

2021

MSPCL

Total Assets

183.08 M

177.07 M


Net Worth

165.97 M

162.51 M


Income

77.68 M

77.12 M


Expenditure

73.53 M

70.15 M


PBT

4.15 M

6.98 M


Tax

4.31 M

(2.22) M


PAT

8.46 M

9.19 M

Site map
©

Druk Holding & Investments Limited.